Tenet Healthcare Co. (NYSE:THC) Director Richard W. Fisher Sells 836 Shares

Tenet Healthcare Co. (NYSE:THC - Get Free Report) Director Richard W. Fisher sold 836 shares of the firm's stock in a transaction that occurred on Thursday, June 5th. The stock was sold at an average price of $173.16, for a total transaction of $144,761.76. Following the completion of the transaction, the director now directly owns 11,292 shares of the company's stock, valued at $1,955,322.72. This represents a 6.89% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.

Tenet Healthcare Stock Performance

Shares of NYSE:THC traded down $0.48 on Friday, hitting $171.36. 1,351,072 shares of the company were exchanged, compared to its average volume of 1,523,627. The company's 50 day moving average price is $144.43 and its two-hundred day moving average price is $137.09. Tenet Healthcare Co. has a one year low of $109.82 and a one year high of $174.14. The company has a debt-to-equity ratio of 2.25, a quick ratio of 1.70 and a current ratio of 1.78. The firm has a market capitalization of $15.92 billion, a price-to-earnings ratio of 5.32, a PEG ratio of 1.02 and a beta of 1.65.

Tenet Healthcare (NYSE:THC - Get Free Report) last posted its quarterly earnings data on Tuesday, April 29th. The company reported $4.36 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.11 by $1.25. Tenet Healthcare had a net margin of 15.48% and a return on equity of 21.88%. The company had revenue of $5.22 billion for the quarter, compared to the consensus estimate of $5.15 billion. During the same quarter in the previous year, the firm posted $3.22 EPS. The business's revenue was down 2.5% compared to the same quarter last year. Research analysts expect that Tenet Healthcare Co. will post 12.24 earnings per share for the current year.

Institutional Trading of Tenet Healthcare

Institutional investors have recently made changes to their positions in the business. Nuveen LLC acquired a new position in Tenet Healthcare in the first quarter valued at about $218,549,000. Ameriprise Financial Inc. raised its stake in shares of Tenet Healthcare by 348.4% during the first quarter. Ameriprise Financial Inc. now owns 1,962,314 shares of the company's stock worth $263,905,000 after buying an additional 1,524,642 shares during the last quarter. Norges Bank bought a new stake in shares of Tenet Healthcare during the fourth quarter worth approximately $190,819,000. Boston Partners increased its stake in Tenet Healthcare by 692.9% in the first quarter. Boston Partners now owns 1,162,642 shares of the company's stock valued at $156,318,000 after purchasing an additional 1,016,010 shares in the last quarter. Finally, Wealthfront Advisers LLC bought a new stake in Tenet Healthcare in the fourth quarter valued at approximately $69,059,000. 95.44% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research firms have issued reports on THC. Cantor Fitzgerald reiterated an "overweight" rating and issued a $177.00 target price on shares of Tenet Healthcare in a research report on Thursday, February 13th. Royal Bank of Canada increased their target price on shares of Tenet Healthcare from $183.00 to $189.00 and gave the stock an "outperform" rating in a research report on Wednesday, April 30th. Robert W. Baird reiterated a "neutral" rating and issued a $137.00 target price (down previously from $153.00) on shares of Tenet Healthcare in a research report on Tuesday, April 15th. Baird R W downgraded shares of Tenet Healthcare from a "strong-buy" rating to a "hold" rating in a report on Tuesday, April 15th. Finally, TD Cowen began coverage on shares of Tenet Healthcare in a report on Wednesday, February 26th. They set a "buy" rating and a $175.00 price target on the stock. Four analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, Tenet Healthcare currently has an average rating of "Moderate Buy" and an average target price of $180.18.

About Tenet Healthcare

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.